In a Phase III trial of 886 patients, Keytruda, a PD-1 inhibitor, plus Padcev, an antibody-drug conjugate, reduced the risk of death by 53% over platinum-based chemotherapy
Smolic T, Zorec R, Vardjan N
The results, tracked via proton magnetic resonance spectroscopy, were highly promising: the NAC supplementation successfully returned cortical glutathione, ventricular lactate, and oxidative stress levels back to normal, which correlated directly with a significant reduction in patient fatigue
It is also now prescribed for patients aged 12 and up, thanks to approval for teenagers in late 2022
PM has also been linked to impurities and acne, allergies, age spots (hyperpigmentation), sensitivity, vitamin E deficiency, mutations and even skin cancer
This is why planning your vial purchases around your escalation schedule matters